BRUNETTI, ORONZO
BRUNETTI, ORONZO
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery
2021-01-01 Shadbad, Mahdi Abdoli; Asadzadeh, Zahra; Derakhshani, Afshin; Hosseinkhani, Negar; Mokhtarzadeh, Ahad; Baghbanzadeh, Amir; Hajiasgharzadeh, Khalil; Brunetti, Oronzo; Argentiero, Antonella; Racanelli, Vito; Silvestris, Nicola; Baradaran, Behzad
Angiogenesis in adenosquamous cancer of pancreas
2017-01-01 Silvestris, Nicola; Danza, Katia; Longo, Vito; Brunetti, Oronzo; Fucci, Livia; Argentiero, Antonella; Calabrese, Angela; Cataldo, Ivana; Tamma, Roberto; Ribatti, Domenico; Tommasi, Stefania
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue
2016-01-01 Longo, Vito; Brunetti, Oronzo; Gnoni, Antonio; Cascinu, Stefano; Gasparini, Giampietro; Lorusso, Vito; Ribatti, Domenico; Silvestris, Nicola
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
2020-01-01 Argentiero, Antonella; Solimando, Antonio Giovanni; Krebs, Markus; Leone, Patrizia; Susca, Nicola; Brunetti, Oronzo; Racanelli, Vito; Vacca, Angelo; Silvestris, Nicola
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review
2017-01-01 Casadei Gardini, A.; Santini, D.; Aprile, G.; Silvestris, N.; Felli, E.; Foschi, F. G.; Ercolani, G.; Marisi, G.; Valgiusti, M.; Passardi, A.; Puzzoni, M.; Silletta, M.; Brunetti, O.; Cardellino, G. G.; Frassineti, G. L.; Scartozzi, M.
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines
2020-01-01 Cellini, F.; Arcelli, A.; Simoni, N.; Caravatta, L.; Buwenge, M.; Calabrese, A.; Brunetti, O.; Genovesi, D.; Mazzarotto, R.; Deodato, F.; Mattiucci, G. C.; Silvestris, N.; Valentini, V.; Morganti, A. G.
Bone metastases in biliary cancers: A multicenter retrospective survey
2018-01-01 Santini, D.; Brandi, G.; Aprile, G.; Russano, M.; Cereda, S.; Leone, F.; Lonardi, S.; Fornaro, L.; Scartozzi, M.; Silvestris, N.; Barni, S.; Pantano, F.; Vincenzi, B.; Palloni, A.; Frega, G.; Casagrande, M.; Ferrari, L.; Dadduzio, V.; Intini, R.; Filippi, R.; Vasile, E.; Vivaldi, C.; Faloppi, L.; Brunetti, O.; Reni, M.; Aglietta, M.; Tonini, G.
Bone metastases in hepatocellular carcinoma: an emerging issue
2014-01-01 Longo, Vito; Brunetti, Oronzo; D'Oronzo, Stella; Ostuni, Carmela; Gatti, Pietro; Silvestris, Franco
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review
2019-01-01 Argentiero, A.; Calabrese, A.; Solimando, A. G.; Notaristefano, A.; Panarelli, M. M. G.; Brunetti, O.
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
2019-01-01 Porcelli, Letizia; Iacobazzi, Rosa Maria; Di Fonte, Roberta; Serrati', Simona; Intini, Angelica; Solimando, Antonio Giovanni; Brunetti, Oronzo; Calabrese, Angela; Leonetti, Francesco; Azzariti, Amalia; Silvestris, Nicola
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM)
2020-01-01 Silvestris, N.; Brunetti, O.; Bittoni, A.; Cataldo, I.; Corsi, D.; Crippa, S.; D'Onofrio, M.; Fiore, M.; Giommoni, E.; Milella, M.; Pezzilli, R.; Vasile, E.; Reni, M.
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
2020-01-01 Kooshkaki, O.; Derakhshani, A.; Hosseinkhani, N.; Torabi, M.; Safaei, S.; Brunetti, O.; Racanelli, V.; Silvestris, N.; Baradaran, B.
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option?
2019-01-01 Argentiero, Antonella; Brunetti, Oronzo; Calabrese, Angela; Sciacovelli, Angela Monica; Delcuratolo, Sabina; Solimando, Antonio Giovanni; Silvestris, Nicola
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?
2020-01-01 Brunetti, Oronzo; Derakhshani, Afshin; Baradaran, Behzad; Galvano, Antonio; Russo, Antonio; Silvestris, Nicola
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine
2021-01-01 Derakhshani, A.; Hashemzadeh, S.; Asadzadeh, Z.; Shadbad, M. A.; Rasibonab, F.; Safarpour, H.; Jafarlou, V.; Solimando, A. G.; Racanelli, V.; Singh, P. K.; Najafi, S.; Javadrashid, D.; Brunetti, O.; Silvestris, N.; Baradaran, B.
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib
2015-01-01 Casadei Gardini, A.; Marisi, G.; Scarpi, E.; Scartozzi, M.; Faloppi, L.; Silvestris, N.; Masi, G.; Vivaldi, C.; Brunetti, O.; Tamberi, S.; Foschi, F. G.; Tamburini, E.; Tenti, E.; Ricca Rosellini, S.; Ulivi, P.; Cascinu, S.; Nanni, O.; Frassineti, G. L.
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
2019-01-01 Longo, Vito; Brunetti, Oronzo; Gnoni, Antonio; Licchetta, Antonella; Delcuratolo, Sabina; Memeo, Riccardo; Solimando, Antonio Giovanni; Argentiero, Antonella
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells
2015-01-01 Simone, Valeria; Ciavarella, Sabino; Brunetti, Oronzo; Savonarola, Annalisa; Cives, Mauro; Tucci, MARCO GAETANO; Opinto, Giuseppina; Maiorano, Eugenio; Silvestris, Francesco
Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer
2020-01-01 Derakhshani, A.; Silvestris, N.; Hajiasgharzadeh, K.; Mahmoudzadeh, S.; Fereidouni, M.; Paradiso, A. V.; Brunetti, O.; Atarod, D.; Safarpour, H.; Baradaran, B.
Fisiologia V Ed.
2016-01-01 Alloatti, G.; Bagni, M. A.; Brunetti, O.; Buffelli, M. R.; Cacchio, M.; Crispino, M.; Mirabella, Giorgia; Occhiuto, F.; Pessia, M.; Rivolta, I.; Scalera, V.; Scarniti, E.; Sirangelo, I.; Tesi, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery | 1-gen-2021 | Shadbad, Mahdi Abdoli; Asadzadeh, Zahra; Derakhshani, Afshin; Hosseinkhani, Negar; Mokhtarzadeh, Ahad; Baghbanzadeh, Amir; Hajiasgharzadeh, Khalil; Brunetti, Oronzo; Argentiero, Antonella; Racanelli, Vito; Silvestris, Nicola; Baradaran, Behzad | |
| Angiogenesis in adenosquamous cancer of pancreas | 1-gen-2017 | Silvestris, Nicola; Danza, Katia; Longo, Vito; Brunetti, Oronzo; Fucci, Livia; Argentiero, Antonella; Calabrese, Angela; Cataldo, Ivana; Tamma, Roberto; Ribatti, Domenico; Tommasi, Stefania | |
| Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue | 1-gen-2016 | Longo, Vito; Brunetti, Oronzo; Gnoni, Antonio; Cascinu, Stefano; Gasparini, Giampietro; Lorusso, Vito; Ribatti, Domenico; Silvestris, Nicola | |
| Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma | 1-gen-2020 | Argentiero, Antonella; Solimando, Antonio Giovanni; Krebs, Markus; Leone, Patrizia; Susca, Nicola; Brunetti, Oronzo; Racanelli, Vito; Vacca, Angelo; Silvestris, Nicola | |
| Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review | 1-gen-2017 | Casadei Gardini, A.; Santini, D.; Aprile, G.; Silvestris, N.; Felli, E.; Foschi, F. G.; Ercolani, G.; Marisi, G.; Valgiusti, M.; Passardi, A.; Puzzoni, M.; Silletta, M.; Brunetti, O.; Cardellino, G. G.; Frassineti, G. L.; Scartozzi, M. | |
| Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines | 1-gen-2020 | Cellini, F.; Arcelli, A.; Simoni, N.; Caravatta, L.; Buwenge, M.; Calabrese, A.; Brunetti, O.; Genovesi, D.; Mazzarotto, R.; Deodato, F.; Mattiucci, G. C.; Silvestris, N.; Valentini, V.; Morganti, A. G. | |
| Bone metastases in biliary cancers: A multicenter retrospective survey | 1-gen-2018 | Santini, D.; Brandi, G.; Aprile, G.; Russano, M.; Cereda, S.; Leone, F.; Lonardi, S.; Fornaro, L.; Scartozzi, M.; Silvestris, N.; Barni, S.; Pantano, F.; Vincenzi, B.; Palloni, A.; Frega, G.; Casagrande, M.; Ferrari, L.; Dadduzio, V.; Intini, R.; Filippi, R.; Vasile, E.; Vivaldi, C.; Faloppi, L.; Brunetti, O.; Reni, M.; Aglietta, M.; Tonini, G. | |
| Bone metastases in hepatocellular carcinoma: an emerging issue | 1-gen-2014 | Longo, Vito; Brunetti, Oronzo; D'Oronzo, Stella; Ostuni, Carmela; Gatti, Pietro; Silvestris, Franco | |
| Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review | 1-gen-2019 | Argentiero, A.; Calabrese, A.; Solimando, A. G.; Notaristefano, A.; Panarelli, M. M. G.; Brunetti, O. | |
| CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer | 1-gen-2019 | Porcelli, Letizia; Iacobazzi, Rosa Maria; Di Fonte, Roberta; Serrati', Simona; Intini, Angelica; Solimando, Antonio Giovanni; Brunetti, Oronzo; Calabrese, Angela; Leonetti, Francesco; Azzariti, Amalia; Silvestris, Nicola | |
| Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) | 1-gen-2020 | Silvestris, N.; Brunetti, O.; Bittoni, A.; Cataldo, I.; Corsi, D.; Crippa, S.; D'Onofrio, M.; Fiore, M.; Giommoni, E.; Milella, M.; Pezzilli, R.; Vasile, E.; Reni, M. | |
| Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials | 1-gen-2020 | Kooshkaki, O.; Derakhshani, A.; Hosseinkhani, N.; Torabi, M.; Safaei, S.; Brunetti, O.; Racanelli, V.; Silvestris, N.; Baradaran, B. | |
| Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? | 1-gen-2019 | Argentiero, Antonella; Brunetti, Oronzo; Calabrese, Angela; Sciacovelli, Angela Monica; Delcuratolo, Sabina; Solimando, Antonio Giovanni; Silvestris, Nicola | |
| COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients? | 1-gen-2020 | Brunetti, Oronzo; Derakhshani, Afshin; Baradaran, Behzad; Galvano, Antonio; Russo, Antonio; Silvestris, Nicola | |
| Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine | 1-gen-2021 | Derakhshani, A.; Hashemzadeh, S.; Asadzadeh, Z.; Shadbad, M. A.; Rasibonab, F.; Safarpour, H.; Jafarlou, V.; Solimando, A. G.; Racanelli, V.; Singh, P. K.; Najafi, S.; Javadrashid, D.; Brunetti, O.; Silvestris, N.; Baradaran, B. | |
| Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib | 1-gen-2015 | Casadei Gardini, A.; Marisi, G.; Scarpi, E.; Scartozzi, M.; Faloppi, L.; Silvestris, N.; Masi, G.; Vivaldi, C.; Brunetti, O.; Tamberi, S.; Foschi, F. G.; Tamburini, E.; Tenti, E.; Ricca Rosellini, S.; Ulivi, P.; Cascinu, S.; Nanni, O.; Frassineti, G. L. | |
| Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma | 1-gen-2019 | Longo, Vito; Brunetti, Oronzo; Gnoni, Antonio; Licchetta, Antonella; Delcuratolo, Sabina; Memeo, Riccardo; Solimando, Antonio Giovanni; Argentiero, Antonella | |
| Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells | 1-gen-2015 | Simone, Valeria; Ciavarella, Sabino; Brunetti, Oronzo; Savonarola, Annalisa; Cives, Mauro; Tucci, MARCO GAETANO; Opinto, Giuseppina; Maiorano, Eugenio; Silvestris, Francesco | |
| Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer | 1-gen-2020 | Derakhshani, A.; Silvestris, N.; Hajiasgharzadeh, K.; Mahmoudzadeh, S.; Fereidouni, M.; Paradiso, A. V.; Brunetti, O.; Atarod, D.; Safarpour, H.; Baradaran, B. | |
| Fisiologia V Ed. | 1-gen-2016 | Alloatti, G.; Bagni, M. A.; Brunetti, O.; Buffelli, M. R.; Cacchio, M.; Crispino, M.; Mirabella, Giorgia; Occhiuto, F.; Pessia, M.; Rivolta, I.; Scalera, V.; Scarniti, E.; Sirangelo, I.; Tesi, C. |